News Daily News FDA Safety Communication Updates Stance on Endologix AAA Grafts L.A. McKeown January 13, 2022
News Features As COVID-19 Vaccine Boosters Roll Out to Younger Kids, Will Myocarditis Cases Rise? Todd Neale January 13, 2022
News Daily News Shorter Anticoagulation an Option for Young Patients With Provoked VTE Todd Neale January 11, 2022
News Daily News Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S Caitlin E. Cox January 07, 2022
News Daily News CDC Extends COVID-19 Boosters to Adolescents, but Myocarditis Is Top of Mind Todd Neale January 06, 2022
News Daily News Ad Hoc PCI Outcomes Similar No Matter Who Does the Diagnostic Cath Todd Neale January 04, 2022
News Daily News Progress Against Acute MI Deaths in Nonelderly US Adults Has Plateaued L.A. McKeown December 30, 2021
News Daily News MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission Todd Neale December 29, 2021
News Daily News AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD Caitlin E. Cox December 28, 2021
News Opinion Editor's Corner Glancing Back, Looking Forward: Lasting Lessons for Years to Come Shelley Wood December 27, 2021
News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study Todd Neale December 27, 2021
News Features FFR’s Future: Negative Trials Spur Debate Over Technology’s Role Michael O'Riordan December 23, 2021
News Daily News Women Less Likely Than Men to Experience SCD During Sports Michael O'Riordan December 21, 2021
News Features Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign L.A. McKeown December 20, 2021